Omkar Pharmachem Ltd (OMKARPH) — shareholding pattern, promoter holding, financials and share price

At ₹17 a share on 10 Jul 2026, Omkar Pharmachem Ltd (OMKARPH) was valued at a price-to-earnings ratio of 131.88x against an industry P/E of 45.11x and a price-to-book of 1.82x on a book value of ₹9.35 per share as of Mar 2025. Solomo computes return on equity of 1.38% and return on capital employed of 1.78% from filed results. Earnings ratios use standalone results for the twelve months Jun 2025 to Mar 2026.

P/E

131.88x

Industry P/E

45.11x

P/B

1.82x

EPS (TTM)

₹0.13

Book value / share

₹9.35

ROE

1.38%

ROCE

1.78%

ROA

1.35%

Debt / equity

0.01x

Dividend yield

0%

52-week range

₹17 – ₹29.74

Ratios are computed from filed results and the last recorded price. Not investment advice.

In the year ended Mar 2026, Omkar Pharmachem Ltd (OMKARPH) reported revenue of ₹0.47 crore, net profit of ₹0.12 crore and earnings per share of ₹0.12. That compares with revenue of ₹0.54 crore and net profit of ₹0.2 crore in Mar 2025. Figures are standalone, as filed with the exchanges.

In the quarter ended Mar 2026, revenue was ₹0.09 crore and net profit ₹0.02 crore (standalone).